Compare XERS & ELVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XERS | ELVR |
|---|---|---|
| Founded | 2005 | 2000 |
| Country | United States | Australia |
| Employees | N/A | 230 |
| Industry | Biotechnology: Pharmaceutical Preparations | Mining & Quarrying of Nonmetallic Minerals (No Fuels) |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 941.8M |
| IPO Year | 2021 | N/A |
| Metric | XERS | ELVR |
|---|---|---|
| Price | $6.19 | $87.91 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $10.83 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 78.8K |
| Earning Date | 05-07-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 100.00 | N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $49,590,000.00 | N/A |
| Revenue This Year | $34.37 | $90.73 |
| Revenue Next Year | $22.86 | $42.59 |
| P/E Ratio | $623.50 | ★ N/A |
| Revenue Growth | ★ 142.67 | N/A |
| 52 Week Low | $4.30 | $15.55 |
| 52 Week High | $10.08 | $101.50 |
| Indicator | XERS | ELVR |
|---|---|---|
| Relative Strength Index (RSI) | 49.90 | 53.50 |
| Support Level | $5.81 | $77.29 |
| Resistance Level | $6.41 | $101.50 |
| Average True Range (ATR) | 0.31 | 3.55 |
| MACD | -0.02 | -1.17 |
| Stochastic Oscillator | 30.21 | 43.85 |
Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.
Elevra Lithium Ltd is a mineral exploration and development company. The principal activity of the company is the identification, acquisition, and evaluation of mineral exploration assets, focusing on lithium. The projects of the company include the Moblan Lithium Project, the Carolina Lithium Project, the Ewoyaa Lithium Project, North American Lithium, and other projects. The company also holds an interest in a tenement portfolio in the Pilbara region, prospective for gold and lithium.